CDC and FDA expedited availability of additional doses of new RSV immunization for infants
On Nov. 16, 2023, the CDC announced the release of more than 77,000 additional doses of Beyfortusï¾™ (nirsevimab-alip…
On Nov. 16, 2023, the CDC announced the release of more than 77,000 additional doses of Beyfortusï¾™ (nirsevimab-alip…
On Nov. 16. 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Following years of…
On Nov. 15, 2023, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple…
On Nov. 13, 2023, the Journal JAMA reported evidence that showed COVID-19 had widened the gendered life expectancy…
On Nov. 13, 2023, the U.S. Department of Department of Agriculture (USDA) announced that researchers have reclassified the…
On Nov. 10, 2023, the CDC estimated that from Oct. 1, 2023, through Nov. 11, 2023, there were…
On Nov. 9, 2023, the U.S. Food and Drug Administration approved Valneva’s Ixchiq, the first chikungunya vaccine. Ixchiq…
On Nov. 9, 2023, the U.S. Food and Drug Administration approved ‘ Takeda PharmaceuticalsVAdzynma, the first recombinant (genetically…
On Nov. 9, 2023, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) antigen…
On Nov. 9, 2023, the National Institute of health (NIH) announced that Monica M. Bertagnolli, M.D., had begun…
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
On Nov. 7, 2023, the World Health Organization (WHO) announced that it had released a new guidance: モWhole…
On Nov. 6, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that it was conducting…
On Nov. 6, 2023, the U.S. Department of Agricultureï¾’s (USDA) announced that nearly 1 million chickens on a…
On Nov. 2, 2023, Abbott announced that it had received U.S. Food and Drug Administration (FDA) approval for…
On Nov. 1, 2023, the International Health Regulations (IHR) National Focal Point of Zambia notified WHO of an…
On Oct. 31, 2023, Novartis announced that the US Food and Drug Administration (FDA) had approved Cosentyxï¾® (secukinumab)…
On Oct. 31, 2023, the U.S. Food and Drug Administration announced it had approved Amgen’s Wezlana (ustekinumab-auub) as…
On Oct. 25, 2023, Bavarian Nordic announced that the U.S. Centers for Disease Control and Preventionï¾’s (CDC) Advisory…
On Oct. 24, 2023, the U.S. Food and Drug Administration approved Servier Pharmaceuticals’ Tibsovo (ivosidenib) for the treatment…
On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…
On Oct. 18, 2023, an industry-academic initiative was announced that aimed to create the largest ever database of…
On Oct. 16. 2023, the U.S. Dept. of Health and Human Services reported results of an audit that…
On Oct. 15, 2023, a dengue outbreak was declared by the Ministry of Public Health and Prevention in…
On Oct. 13, 2023, the National Institute of health (NIH) announced that an investigational drug, encaleret, restored calcium…
On Oct. 12, 2023, the National Institute of health (NIH) announced that a group of international scientists had…
On Oct. 12, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that two fatal human…
On Oct. 11, 2023, the U.S. Food and Drug Administration announced the creation of a new Digital Health…
On Oct. 10, 2023, the University of Wisconsin-Madison researchers announced a new study published in the journal Neuron…
On Oct. 9, 2023, GlaxoSmithKline announced that it had reached an exclusive agreement with Chongqing Zhifei Biological Products…